Skip to Content

Cisatracurium Besylate Injection

Last Updated: September 9, 2016
Status: Current

Products Affected - Description

All presentations are currently available

Reason for the Shortage

Fresenius Kabi had cisatracurium besylate injection on shortage due to increased demand.

Available Products

Nimbex injection, AbbVie
2 mg/mL, 5 mL vial, 10 count (NDC 00074-4378-05)

2 mg/mL, 10 mL vial, 10 count (NDC 00074-4380-10)
10 mg/mL, 20 mL vial, 10 count (NDC 00074-4382-20)
 
Cisatracurium besylate injection, Fresenius Kabi
2 mg/mL, 5 mL vial, 10 count (NDC 63323-0416-05)
2 mg/mL, 10 mL vial, 10 count (NDC 63323-0417-10)
10 mg/mL, 20 mL vial, 10 count (NDC 63323-0418-20)
 
Cisatracurium besylate injection, Sandoz
2 mg/mL, 5 mL vial, 10 count (NDC 00781-3150-95)
2 mg/mL, 10 mL vial, 10 count (NDC 00781-3152-95)
10 mg/mL, 20 mL vial, 10 count (NDC 00781-3153-95)

Estimated Resupply Dates

All marketed presentations are available.

Related Shortages

Updated

September 9, August 25, July 28 and 7, June 9, May 24, April 14, 2016, University of Utah, Drug Information Service. Copyright 2016, Drug Information Service, University of Utah, Salt Lake City, UT.

Hide